154 related articles for article (PubMed ID: 10036999)
1. The peripheral cannabinoid receptor, Cb2, in retrovirally-induced leukemic transformation and normal hematopoiesis.
Valk PJ; Delwel R
Leuk Lymphoma; 1998 Dec; 32(1-2):29-43. PubMed ID: 10036999
[TBL] [Abstract][Full Text] [Related]
2. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
3. Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells.
Valk P; Verbakel S; Vankan Y; Hol S; Mancham S; Ploemacher R; Mayen A; Löwenberg B; Delwel R
Blood; 1997 Aug; 90(4):1448-57. PubMed ID: 9269762
[TBL] [Abstract][Full Text] [Related]
4. Leukemic predisposition of pSca-1/Cb2 transgenic mice.
Joosten M; Valk PJ; Jordà MA; Vankan-Berkhoudt Y; Verbakel S; van den Broek M; Beijen A; Löwenberg B; Delwel R
Exp Hematol; 2002 Feb; 30(2):142-9. PubMed ID: 11823049
[TBL] [Abstract][Full Text] [Related]
5. Identification, characterization, and function of a novel oncogene: the peripheral cannabinoid receptor Cb2.
Jorda MA; Rayman N; Valk P; De Wee E; Delwel R
Ann N Y Acad Sci; 2003 May; 996():10-6. PubMed ID: 12799277
[TBL] [Abstract][Full Text] [Related]
6. Retroviral insertions in Evi12, a novel common virus integration site upstream of Tra1/Grp94, frequently coincide with insertions in the gene encoding the peripheral cannabinoid receptor Cnr2.
Valk PJ; Vankan Y; Joosten M; Jenkins NA; Copeland NG; Löwenberg B; Delwel R
J Virol; 1999 May; 73(5):3595-602. PubMed ID: 10196250
[TBL] [Abstract][Full Text] [Related]
7. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.
Facci L; Dal Toso R; Romanello S; Buriani A; Skaper SD; Leon A
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3376-80. PubMed ID: 7724569
[TBL] [Abstract][Full Text] [Related]
8. The genes encoding the peripheral cannabinoid receptor and alpha-L-fucosidase are located near a newly identified common virus integration site, Evi11.
Valk PJ; Hol S; Vankan Y; Ihle JN; Askew D; Jenkins NA; Gilbert DJ; Copeland NG; de Both NJ; Löwenberg B; Delwel R
J Virol; 1997 Sep; 71(9):6796-804. PubMed ID: 9261404
[TBL] [Abstract][Full Text] [Related]
9. Behavioral effects of cannabinoid agents in animals.
Chaperon F; Thiébot MH
Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
[TBL] [Abstract][Full Text] [Related]
10. The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation.
Jordà MA; Lowenberg B; Delwel R
Blood; 2003 Feb; 101(4):1336-43. PubMed ID: 12406867
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL
Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624
[TBL] [Abstract][Full Text] [Related]
12. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
[TBL] [Abstract][Full Text] [Related]
13. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
[TBL] [Abstract][Full Text] [Related]
15. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.
McKallip RJ; Lombard C; Fisher M; Martin BR; Ryu S; Grant S; Nagarkatti PS; Nagarkatti M
Blood; 2002 Jul; 100(2):627-34. PubMed ID: 12091357
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
Showalter VM; Compton DR; Martin BR; Abood ME
J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic cells expressing the peripheral cannabinoid receptor migrate in response to the endocannabinoid 2-arachidonoylglycerol.
Jordà MA; Verbakel SE; Valk PJ; Vankan-Berkhoudt YV; Maccarrone M; Finazzi-Agrò A; Löwenberg B; Delwel R
Blood; 2002 Apr; 99(8):2786-93. PubMed ID: 11929767
[TBL] [Abstract][Full Text] [Related]
18. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures.
Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ
J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
Rao GK; Kaminski NE
J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of cannabinoid CB1 and CB2 receptors.
Pertwee RG
Pharmacol Ther; 1997; 74(2):129-80. PubMed ID: 9336020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
